130-85-8帕莫酸,98%
- 发布日期: 2018-11-21
- 更新日期: 2025-07-04
产品详请
产地 |
中国/美国/欧洲
|
品牌 |
LMAI Bio
|
货号 |
LM011626
|
英文名称 |
Pamoic acid
|
包装规格 |
100g 25g 500g
|
纯度 |
99%
|
CAS编号 |
130-85-8
|
别名 |
哌酸; 亚甲基双羟萘酸; 4,4'-亚甲基二(3-羟基-2-萘甲酸); 扑酸; 2,2'-二羟基-1,1'-二萘甲烷-3,3'-二羧酸;
|
分子式 |
C23H16O6
|
130-85-8帕莫酸,98%
CAS号: 130-85-8
分子式: C23H16O6 分子量: 388.38

帕莫酸
英文名:pamoic acid
CAS: | 130-85-8 | 精确质量: | 388.09500 |
分子式: | C23H16O6 | LogP: | 4.39140 |
分子量: | 388.37000 | PSA: | 115.06000 |
130-85-8帕莫酸,98%化合物描述
Pamoic acid, also called embonic acid, is a naphthoic acid derivative. Salts and esters of pamoic acid are known as pamoates or embonates. It can be prepared by the reaction of 2-hydroxy-3-naphthoic acid with formaldehyde.
In pharmacology, the salt form of pamoic acid (pamoate ion) can be used as a counter ion of a drug compound to increase the solubility of the drug in water. The presence of multiple oxygen atoms enables significant hydrogen bonding to occur. Hydrogen bonds facilitate the dissolution of compounds in water.
Pamoic acid has agonist activity for the orphan G protein-coupled receptor GPR35 by which it activates ERK and beta-arrestin2, and causes antinociceptive activity. Although (like other drug salts) it has been considered an inactive compound by the FDA, these recent data suggest that its permitted uses may need to be reexamined.
130-85-8帕莫酸,98%基本信息
中文名称:
帕莫酸
中文别名:
哌酸;
亚甲基双羟萘酸;
4,4'-亚甲基二(3-羟基-2-萘甲酸);
扑酸;
2,2'-二羟基-1,1'-二萘甲烷-3,3'-二羧酸;
英文名称:
pamoic acid
英文别名:
Pamoic;
Pamoic Acid;
1,1'-Methylene-bis(2-hydroxy-3-naphthoic acid);
2-Naphthalenecarboxylic acid, 4,4‘-methylenebis[3-hydroxy-;
4,4-Methylenebis(3-Hydroxy-2-Naphthoic Acid);
EMBIONIC ACID;
PAMOIC ACID FREE ACID;
Pamoic acid;
PAMOIC ACID pure;
Embonic acid;
4,4'-Methylenebis(3-hydroxy-2-naphthoic Acid);
CAS号:
130-85-8
分子式:
C23H16O6
分子量:
388.37000
精确质量:
388.09500
PSA:
115.06000
LogP:
4.39140
物化性质
安全信息
安全说明:
S26-S36
海关编码:
2917399090
危险品标志:
Xi
危险类别码:
R36/37/38
RTECS号:
QL2180000
WGK Germany:
3
生产方法及用途